Program brings top cancer expertise to the Outer Banks
UNC-developed technique has broad applications in cancer, biomedical research
Local Group Bikes Across the Country to Raise Money for UNC Lineberger
UNC Lineberger Genetics Policy, Law, Medicine Expert Discusses March 29, 2010 US District Court Gene Patenting Ruling
Group Received ASCO 2010 Clinical Trial Participation Award
Strategic Partnership to Advance Nanotechnology-Based Diagnosis and Treatment
Discovery has potential for cancer patients and disaster victims
Evans is director of clinical cancer genetics at UNC Lineberger. Article originally published in the June 27, 2010 issue of Newsday.
Nancy Thomas, MD, PhD, Co-Director of UNC’s Interdisciplinary Melanoma Program, talks about sun safety and early detection of skin cancer
This news story was originally published on June 17, 2010 by Campbell University. Reprinted with permission
UNC's Goldberg a Key Contributor
UNC researchers reveal how a protein called Tet1 helps stem cells keep their “stemness” in a paper published in Nature.
UNC Lineberger team will examine minority, underserved populations
Part of UNC Comprehensive Cancer Support Program
The article "How Old Are You, Really?" written by Mark Derewicz and published in the Fall 2010 issue of Endeavors magazine features UNC Lineberger member Ned Sharpless, MD. Dr. Sharpless is an associate professor of medicine and genetics and associate director for translational research at UNC Lineberger.
National Cancer Institute awards $13.6 million to UNC's Carolina Center of Cancer Nanotechnology Excellence
UNC Scientists Receive Grant to Develop Nanotechnology for Pancreatic Cancer Diagnosis and Treatment
Project Focuses on Efficient, Low-Cost Genetic Analysis
ABC Anchor Robin Roberts Guest of Honor at Kickoff Event
N.C. native John Isner and doubles partner Sam Querrey to host
$11.9 Million in awards to address cancer disparities
Toxicity of the anticancer drug CPT-11 is alleviated by inhibiting a specific enzyme (pictured in purple and blue) in human symbiotic gastrointestinal bacteria. Researchers identified compounds (yellow) that target and bind to the enzyme, blocking the reaction that leads to the drug's debilitating side effects. Credit: Bret D. Wallace and Matthew R. Redinbo, UNC-Chapel Hill.
Cell signaling protein may hold key to blocking long-studied genetic mutation
Organization will receive The Artist in Residence Program to help people affected by cancer